These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 8648192)

  • 1. Cholesterol sulfate protects Candida albicans from inhibition by sphingosine in vitro.
    Payne CD; Ray TL; Downing DT
    J Invest Dermatol; 1996 Mar; 106(3):549-52. PubMed ID: 8648192
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interaction between sphingosine and cholesteryl sulfate in epidermal lipids.
    Downing DT; Dose RW; Abraham W
    J Lipid Res; 1993 Apr; 34(4):563-9. PubMed ID: 8496662
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vitro activity of phytosphingosines against Malassezia furfur and Candida albicans.
    Nenoff P; Haustein UF
    Acta Derm Venereol; 2002; 82(3):170-3. PubMed ID: 12353705
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The action of miconazole of the growth of Candida albicans.
    Van Den Bossche H; Willemsens G; Van Cutsem JM
    Sabouraudia; 1975 Mar; 13 Pt 1():63-73. PubMed ID: 1091999
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Stratum corneum lipids in disorders of cornification. Steroid sulfatase and cholesterol sulfate in normal desquamation and the pathogenesis of recessive X-linked ichthyosis.
    Elias PM; Williams ML; Maloney ME; Bonifas JA; Brown BE; Grayson S; Epstein EH
    J Clin Invest; 1984 Oct; 74(4):1414-21. PubMed ID: 6592175
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mechanism of action of nikkomycin and the peptide transport system of Candida albicans.
    McCarthy PJ; Troke PF; Gull K
    J Gen Microbiol; 1985 Apr; 131(4):775-80. PubMed ID: 3886837
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sphingosines: antimicrobial barriers of the skin.
    Bibel DJ; Aly R; Shah S; Shinefield HR
    Acta Derm Venereol; 1993 Dec; 73(6):407-11. PubMed ID: 7906449
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibitors of protein phosphorylation including the retinoblastoma protein induce germination of Candida albicans.
    Cho T; Hamatake H; Hagihara Y; Kaminishi H
    Med Mycol; 2000 Feb; 38(1):41-5. PubMed ID: 10746226
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antimicrobial activity of sphingosines.
    Bibel DJ; Aly R; Shinefield HR
    J Invest Dermatol; 1992 Mar; 98(3):269-73. PubMed ID: 1545135
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Studies on the antifungal activity of the new imidazole antimycotic lanoconazole in infected sites. Distribution in the skin and in vitro activity in the presence of stratum corneum.
    Niwano Y; Matsui M; Tabuchi T; Kanai K; Hamaguchi H; Miyazaki T; Uchida K; Yamaguchi H
    Arzneimittelforschung; 1997 Sep; 47(9):1056-60. PubMed ID: 9342423
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evaluation of polyene-azole antagonism in liquid cultures of Candida albicans using an automated turbidometric method.
    Samaranayake YH; Samaranayake LP; Yeung KW
    Chemotherapy; 2001; 47(4):279-91. PubMed ID: 11399865
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mutation of G234 amino acid residue in candida albicans drug-resistance-related protein Rta2p is associated with fluconazole resistance and dihydrosphingosine transport.
    Zhang SQ; Miao Q; Li LP; Zhang LL; Yan L; Jia Y; Cao YB; Jiang YY
    Virulence; 2015; 6(6):599-607. PubMed ID: 26220356
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phytosphingosine kills Candida albicans by disrupting its cell membrane.
    Veerman EC; Valentijn-Benz M; van't Hof W; Nazmi K; van Marle J; Amerongen AV
    Biol Chem; 2010 Jan; 391(1):65-71. PubMed ID: 19919184
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A specific inhibitor of keratinolytic proteinase from Candida albicans could inhibit the cell growth of C. albicans.
    Tsuobi R; Kurita Y; Negi M; Ogawa H
    J Invest Dermatol; 1985 Nov; 85(5):438-40. PubMed ID: 3902988
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anti-Candida albicans natural products, sources of new antifungal drugs: A review.
    Zida A; Bamba S; Yacouba A; Ouedraogo-Traore R; Guiguemdé RT
    J Mycol Med; 2017 Mar; 27(1):1-19. PubMed ID: 27842800
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anti-biofilm activity of the metabolites of Streptomyces chrestomyceticus strain ADP4 against Candida albicans.
    Srivastava V; Dubey AK
    J Biosci Bioeng; 2016 Oct; 122(4):434-40. PubMed ID: 27117484
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Correlation of inhibition of sterol synthesis with growth-inhibitory action of imidazole antimycotics in Candida albicans.
    Nicholas RO; Kerridge D
    J Antimicrob Chemother; 1989 Jan; 23(1):7-19. PubMed ID: 2663807
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Skin surface lipids inhibit adherence of Candida albicans to stratum corneum.
    Law S; Fotos PG; Wertz PW
    Dermatology; 1997; 195(3):220-3. PubMed ID: 9407165
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vitro antifungal activity of 2,5 disubstituted amino-oksometyloso-arylo-thiadiazole derivatives.
    Lukaszuk C; Krajewska-Kułak E; Niewiadomy A; Stachowicz J; Głaszcz U; Oksiejczuk E
    Adv Med Sci; 2007; 52 Suppl 1():26-9. PubMed ID: 18229628
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Activated lactoferrin and fluconazole synergism against Candida albicans and Candida glabrata vaginal isolates.
    Naidu AS; Fowler RS; Martinez C; Chen J; Tulpinski J
    J Reprod Med; 2004 Oct; 49(10):800-7. PubMed ID: 15568403
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.